Nautic Partners to acquire KabaFusion from Novo Holdings for $2.2bn.

Nautic Partners, a middle market private equity firm, agreed to acquire KabaFusion, one of the nation’s biggest independent home infusion providers, from Novo Holdings, a holding and investment company for $2.2bn. “We are incredibly proud of what KabaFusion has accomplished—delivering innovative, patient-focused infusion therapies and setting the standard for clinical excellence nationwide. We have known the Nautic team for a long time and they are a natural partner for our business and the management team. As we enter this exciting new chapter, we look forward to leveraging Nautic’s expertise to accelerate our growth. We are confident this partnership will further strengthen our ability to deliver exceptional outcomes and lasting value for the patients and providers we serve,” Dr. Sohail Masood, KabaFusion CEO and founder.